RxDoctor Payments Data

Tzvi Bar-David, DPM

Foot & Ankle Surgery · New York, NYNPI 1912065996

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $36,854 of the $38,724 with a category attached, or 95.2%. 8 manufacturers reported payments, led by Synthes USA Products LLC at 56.1% of the total. 2025 is the largest year on record at $10,811, more than ten times the $178 reported in 2019. Among foot & ankle surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$38,724in general payments, 2019–2025

Across 47 payments — averaging $823.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Synthes USA Products LLC$22K
  • Medical Device Business Services, Inc.$13K
  • Integra Lifesciences Corporation$3K
  • Stryker$270
  • Johnson & Johnson$199
  • Smith+Nephew$83
  • plus $81 from 2 others
$29,250in research payments, 2019–2025

Across 1 payment — averaging $29,250 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$29K

What the payments were for

  • Consulting fees$36,85495%
  • Travel & lodging$7632%
  • Food & beverage$1,1073%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,724 in reported general payments places this provider in the 95th percentile of 652 foot & ankle surgery providers in New York.

See all foot & ankle surgery providers in New York

Medicare billing

Part B allowed, 2024
$168,783
Medicare patients
685
Services billed
1,889

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CiclopiroxCiclopirox Olamine24$683
Ammonium Lactate21$497
Colchicine13$314
Meloxicam67$191
Cephalexin40$157
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$92

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →